Skip to main content
Top
Published in: Intensive Care Medicine 11/2017

Open Access 01-11-2017 | What's New in Intensive Care

Intensive care medicine in 2050: the ICU in vivo

Author: Can Ince

Published in: Intensive Care Medicine | Issue 11/2017

Login to get access

Excerpt

When speculating on how an intensive care unit (ICU) might appear in 2050, the famous saying of the Noble laureate physicist Niels Bohr comes to mind: “prediction is very difficult, especially if it concerns the future.” Nevertheless, the purpose of this paper is to speculate on the diagnostic developments that will define the landscape of the ICU in 2050. In doing so it should be noted that it is the view of a physiologist interested in intensive care medicine and not that of an intensivist. Although it is likely that the future will be dominated by personalized medicine [1], a concept will have to emerge which will be much more suited to the critically ill patient than its current understanding based mainly on genomics and biomarkers [2]. Personalized medicine will need to be more focused on the continuous assessment of the function of the various physiological compartments of the individual critically ill patient [3, 4]. We have termed this concept personalized physiological medicine, as a version of personalized medicine that is more closely related to the physiological needs of the critically ill patient [5]. The principles of personalized physiological medicine are defined by continuous assessment of the physiological reserve and frailty of the patient, the function of the various organ systems, the hierarchy and coherence of the cardiovascular system [6], and finally the integration of physiological variables and therapeutic interventions for control of organ function ([5]; Fig. 1). Personalized physiological medicine could be, in my opinion, the defining platform for the ICU of 2050 as it includes basic concepts from engineering for the control of complex systems [7]. To achieve this aim, continuous and quantitative measurements of essential physiological parameters that relate to organ and cellular function will be required using tailor-made point-of-care technology. To achieve precision medicine, devices and sensors will have to be placed as close as possible to the organs and cells of the patient.
Literature
1.
go back to reference Marini JJ, Vincent JL, Annane D (2015) Critical care evidence-new directions. JAMA 313(9):893–894 (3) CrossRefPubMed Marini JJ, Vincent JL, Annane D (2015) Critical care evidence-new directions. JAMA 313(9):893–894 (3) CrossRefPubMed
2.
go back to reference Christaki E, Giamarellos-Bourboulis EJ (2014) The beginning of personalized medicine in sepsis: small steps to a bright future. Clin Genet 86:56–61CrossRefPubMed Christaki E, Giamarellos-Bourboulis EJ (2014) The beginning of personalized medicine in sepsis: small steps to a bright future. Clin Genet 86:56–61CrossRefPubMed
3.
go back to reference Okusa MD, Jaber BL, Doran P, Duranteau J, Yang L, Murray PT, Mehta RL, Ince C (2013) Physiological biomarkers of acute kidney injury: a conceptual approach to improving outcomes. Contrib Nephrol 182:65–81CrossRefPubMed Okusa MD, Jaber BL, Doran P, Duranteau J, Yang L, Murray PT, Mehta RL, Ince C (2013) Physiological biomarkers of acute kidney injury: a conceptual approach to improving outcomes. Contrib Nephrol 182:65–81CrossRefPubMed
4.
go back to reference Ferrer R, Artigas A (2011) A physiologic parameters as biomarkers: what can we learn from physiologic variables and variation? Crit Care Clin 27:229–240CrossRefPubMed Ferrer R, Artigas A (2011) A physiologic parameters as biomarkers: what can we learn from physiologic variables and variation? Crit Care Clin 27:229–240CrossRefPubMed
5.
go back to reference Ince C (2017) Personalized physiological medicine. Crit Care (in press) Ince C (2017) Personalized physiological medicine. Crit Care (in press)
7.
8.
go back to reference Luke HD (1999) The origins of the sampling theorem. IEEE Commun 37:106–108CrossRef Luke HD (1999) The origins of the sampling theorem. IEEE Commun 37:106–108CrossRef
9.
10.
go back to reference Slomovic S, Pardee K, James J, Collins J (2015) Synthetic biology devices for in vitro and in vivo diagnostics. Proc Natl Acad Sci USA 112(47):14429–14435 (24) CrossRefPubMedPubMedCentral Slomovic S, Pardee K, James J, Collins J (2015) Synthetic biology devices for in vitro and in vivo diagnostics. Proc Natl Acad Sci USA 112(47):14429–14435 (24) CrossRefPubMedPubMedCentral
11.
go back to reference Chatupniak A, Morales-Narvaez E, Merkogi A (2015) Micro and nanomotors in diagnostics. Adv Drug Deliv Rev 1(95):104–116CrossRef Chatupniak A, Morales-Narvaez E, Merkogi A (2015) Micro and nanomotors in diagnostics. Adv Drug Deliv Rev 1(95):104–116CrossRef
12.
go back to reference Pene F, Courtine E, Cariou A, Mira JP (2009) Toward theragnostics. Crit Care Med 37(Suppl.):S50–S58CrossRefPubMed Pene F, Courtine E, Cariou A, Mira JP (2009) Toward theragnostics. Crit Care Med 37(Suppl.):S50–S58CrossRefPubMed
13.
go back to reference Attanasio C, Latancia MT, Otterbein LE, Netti PA (2016) Update on renal replacement therapy: implantable artificial devices and bioengineered organs. Tissue Eng Rev 22(4):330–340CrossRef Attanasio C, Latancia MT, Otterbein LE, Netti PA (2016) Update on renal replacement therapy: implantable artificial devices and bioengineered organs. Tissue Eng Rev 22(4):330–340CrossRef
14.
go back to reference Hunter P (2016) The virtual physiological human: the physiome project aims to develop reproducible, multiscale models for clinical practice. IEEE Pulse 7(4):36–42CrossRefPubMed Hunter P (2016) The virtual physiological human: the physiome project aims to develop reproducible, multiscale models for clinical practice. IEEE Pulse 7(4):36–42CrossRefPubMed
15.
go back to reference Li Xl, Wang Y (2016) Adaptive online monitoring for ICU patients by combining just-in-time learning and principal component analysis. J Clin Monit Comput 30(6):807–820CrossRefPubMed Li Xl, Wang Y (2016) Adaptive online monitoring for ICU patients by combining just-in-time learning and principal component analysis. J Clin Monit Comput 30(6):807–820CrossRefPubMed
Metadata
Title
Intensive care medicine in 2050: the ICU in vivo
Author
Can Ince
Publication date
01-11-2017
Publisher
Springer Berlin Heidelberg
Published in
Intensive Care Medicine / Issue 11/2017
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-017-4808-y

Other articles of this Issue 11/2017

Intensive Care Medicine 11/2017 Go to the issue

Imaging in Intensive Care Medicine

Clostridium perfringens related spleen gangrene

Imaging in Intensive Care Medicine

Multistage ECMO cannulas: first holes get it all?